Related Experiment Video
Updated: Nov 21, 2025

The Multiple Sclerosis Performance Test MSPT: An iPad-Based Disability Assessment Tool
Published on: June 30, 2014
Presenting Symptoms and Disease Severity in Multiple Sclerosis Patients
Jason Ledesma1, Padma Priya Puttagunta1, Shayan Torabi1
1Department of Neurology, The Lundquist Institute, Torrance, CA 90504, USA.
Presenting symptoms in multiple sclerosis (MS) are not linked to disease duration or severity (EDSS/lesion volume). However, sensory symptoms correlated with lower lesion volumes in this MS study.
Area of Science:
- Neurology
- Neuroimmunology
- Clinical Research
Background:
- Multiple sclerosis (MS) is a chronic neurological disease characterized by varying symptoms and progression.
- Assessing disease severity is crucial for patient management and treatment efficacy.
Purpose of the Study:
- To investigate the association between initial symptoms of multiple sclerosis and objective measures of disease severity.
- To determine if presenting symptoms correlate with Expanded Disability Status Scale (EDSS) scores and MRI-defined lesion volumes.
Main Methods:
- Retrospective analysis of data from 29 multiple sclerosis patients collected between 2014-2017.
- Inclusion criteria excluded patients unable to undergo MRI or lab tests, or with pre-existing vitamin abnormalities.
- Presenting symptoms (vision, balance, sensory, motor) were compared against EDSS and MRI lesion volumes.
Main Results:
- No significant differences in EDSS or lesion volumes were found when comparing disease duration groups.
- A notable difference in lesion volumes emerged when comparing patients with visual/balance symptoms versus those with sensory symptoms.
- Sensory symptoms at presentation were associated with smaller lesion volumes.
Conclusions:
- Initial symptoms in multiple sclerosis do not appear to be associated with EDSS-independent disease duration.
- Disease severity, measured by EDSS and lesion volume, is not directly correlated with all presenting symptoms.
- Sensory symptoms may indicate a less aggressive disease course in terms of lesion burden.
Related Concept Videos
Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation
Chronic Kidney Disease II: Clinical Manifestations
Myasthenia Gravis: Diagnostic Tests
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...
Atherosclerosis II: Clinical Manifestations and Diagnostic Tests
Parkinson's Disease: Overview

